Researchers investigate why cancer drug leaves patients gasping for air
NCT ID NCT04827563
Summary
This study aims to understand why some multiple myeloma patients experience shortness of breath when taking the cancer drug carfilzomib. Researchers will use a special device to measure blood vessel health in 50 patients receiving this treatment. The goal is to identify risk factors and potentially find ways to prevent this distressing side effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOTOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.